MarketWatch (press release) About Stivarga(R) (regorafenib) Tablets In the United States, Stivarga is indicated for the treatment of patients with mCRC who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan -based chemotherapy, an anti-VEGF therapy ... and more »
Sacramento Bee Vectibix was approved in the United States in September 2006 as a single agent for the treatment of metastatic colorectal carcinoma with disease progression on or following fluoropyrimidine, oxaliplatin and irinotecan chemotherapy regimens. Approval is ... and more »
FierceBiotech Nexavar in combination with gemcitabine /cisplatin is not recommended in patients with squamous cell lung cancer. The safety and effectiveness of Nexavar has not been established in patients with non-small cell lung cancer. Nexavar can prolong the QT ... and more »
Genetic Engineering News Just as serendipity wrought the discoveries that Viagra did wonders for sexual dysfunction in men, and Dramamine treated travel sickness better than allergies, so too did it cause a seven-year-old Swedish drug developer to reposition the MRI contrast ...
The Pharma Letter Last September, Stivarga was approved for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan -based chemotherapy, an anti-VEGF therapy, and, if KRAS ... and more »
Seeking Alpha Last year, AstraZeneca presented data from a Phase 2 study comparing the efficacy of selumetinib in combination with docetaxel versus docetaxel alone in second-line therapy in 87 patients with KRAS-mutation positive locally advanced or metastatic ... and more »
